Facility Evaluation Report

Licensing Program Analyst (LPA) Cuadra arrived unannounced to conduct a Case Management Inspection and met with Eryn Lugger (Residential Counselor). Administrator, Shanice Moore was not able to come to the facility but was available by phone and gave authorization to staff to sign the report. LPA arrived at the facility and had her temperature checked and was logged into a sign-in sheet.

During today's visit LPA is following up on an incident report received at CCL on 4/11/22 involving Client (C1). On 4/8/22 at around 3:07pm House Manager noticed on the bubble pack that the Risperidone 2mg tablet was still there for the day before 4/7/22 that was supposed to be provided to C1. It was also discovered that medication Lithium Carbonate 300mg was not in the bubble pack. CSU (Physician) was contacted for medical guidance and was advised to continue medication regimen. House Manager notified facility Administrator and responsible parties. Staff (S1) was inquired by House Manager about missing medication and was placed on immediate suspension, removed from shift for a week and won't be assisting clients with medications. Per incident report, staff will receive training and supervision for two weeks. However, there was another incident that occurred on 3/29/22 about missed dosage with same staff and facility provided as a proof of correction a policy indicating how the facility will provide training to staff on medication management and records of the training were also submitted to CCL. Based on incident report received on 4/11/22 the facility is not following their program plan dated 3/29/22.

Deficiencies cited from the California Code of Regulations, Title 22, Division 6 of California Regulation. Appeal rights given. Failure to correct the deficiency and/or repeat deficiencies within a 12-month period may result in civil penalties.

**Civil Penalty assessed in the total amount of $250.00 for repeated violation during visit on 3/29/22.